Effect of Systemic Prednisolone and Topical Tranexamic Acid on Prevention of Rebleeding in Traumatic Hyphema

Phase 2

• Conditions: Hyphema.; Hyphema; H21.0

• Registration Number: IRCT20201110049345N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients with Traumatic Hyphema referred to Mashhad Eye Khatam AlAnbia Hospital

Exclusion Criteria

Microscopic hyphema
Globe rupture
Patients with systemic diseases such as diabetes mellitus, hypertension
Posterior segment pathology except commotio retina
coagulopathy and taking anticoagulants drugs
history of ophthalmic surgery
children under 7years old
pregnant women.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rebleeding. Timepoint: Daily for 5 days and two weeks later. Method of measurement: Slit lamp biomicroscopy.